# Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.

> **NCT04492813** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 40 (actual)

## Conditions studied

- General Anesthesia
- Obesity

## Interventions

- **DRUG:** Pharmacokinetic of propofol and remifentanil

## Key facts

- **NCT ID:** NCT04492813
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2021-01-25
- **Final completion:** 2021-05-25
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04492813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04492813, "Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04492813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*